LOGISTICS & WAREHOUSING
As a result, logistics networks are being redesigned, with a focus on cost savings and resilience. Organisations have seen the value which comes from multimodal logistics providers, especially those which can handle the entire end-toend logistics journey. Through this, they reduce hand-offs – where many of the errors emerge – and have a stronger oversight into regulatory needs and thorough knowledge of storage or technical requirements.
“ We’ re seeing continuous cost pressures accelerate with the amount of uncertainty across major markets, including the US. In response, pharmaceutical and biotech companies are becoming considerably more focused on how they structure their supply chain partnerships,” says Alina.
“ One of the clearest shifts across the industry is a preference for fewer, more strategic provider relationships; with priority to partner with a single 3PL that can bring multiple services under one roof. This model reduces complexity, improves accountability, strengthens connections across the wider pharma supply chain and gives manufacturers access to global scale, network reach and specialist expertise.”
Procurement and supply chain leaders are looking for resilience, visibility, cost savings, simplification and logistics optimisation. Saurabh explains,“ At enterprise scale, three things matter
100 August 2026